Detalhe da pesquisa
1.
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Blood
; 143(2): 118-123, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647647
2.
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Mol Ther
; 31(7): 2089-2104, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945773
3.
Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR.
Mol Ther
; 32(2): 556-558, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38103549
4.
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.
Blood
; 124(8): 1277-87, 2014 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970931
5.
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Nat Commun
; 15(1): 1583, 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383515
6.
Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine Receptors.
Cancer Immunol Res
; 11(9): 1203-1221, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352396
7.
Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2.
Front Immunol
; 14: 1119350, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334382
8.
Tunable control of CAR T cell activity through tetracycline mediated disruption of protein-protein interaction.
Sci Rep
; 11(1): 21902, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34754016
9.
Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma.
Sci Transl Med
; 12(571)2020 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239386